אודותינו חטיבות מוצרים נציגויות אסתטיקה רפואית יצירת קשר English  
     
  דף ראשי גסטרואנטרולוגיה> Stents
  קרדיולוגיה



   
HV Stent - SX-ELLA Stent Esophageal HV

Do you need an esophageal stent with a brilliant flexibility, high expansion force and extremely low migration rate equipped with a reliable antireflux valve?

SX-ELLA Stent Esophageal HV (HV STENT) is designed to meet your requirements

SX-ELLA Stent Esophageal HV - HV STENT is a reliable medical device intended for relieving obstructions in the esophagus, no matter if in upper, middle or lower part. If the stent is deployed in lower part of the esophagus when reaching cardia and stomach, it can be equipped with an antireflux valve to prevent gastric juices attacking the esophageal wall. Implantation of the stent should be performed under fluoroscopic guidance. To yet decrease the migration rate, the HV STENT is equipped with so-called antimigration ring.
hv
 

Additional description

SX-ELLA Stent Esophageal HV - HV STENT (fig. 1) is braided of a wire made of nickel-titanium alloy - nitinol, the properties of which cause the unrivaled flexibility as well as a great corrosion resistance. The fact the stent is braided of one piece of the wire (only the antimigration ring is fixed to the finished stent extra) makes the stent ends non-traumatic, i.e. the stent does not injure the esophageal wall during an actual deployment or reposition if misplaced. The radiopacity of the stent is secured by markers, made of platinum-iridium alloy, that are fixed to a stent mesh; in addition, there are gold-plated markers, fixed to strings at both stent ends. The covering of the stent is made of PE.
Beside the excellent flexibility, the construction of the HV STENT and the material used guarantee a sufficient expansion force.
In general, stents sometimes migrate (into stomach in this instance). To decrease the risk of migration to the very minimum, HV STENT is equipped with an antimigration ring that is fixed thereto circumferentially in the proximal portion. However, if the HV STENT migrates after all, the strings at both stent ends may be used for removal of the stent out of the body or for reposition as mentioned hereinbefore.
HV STENT, if to be implanted into lower part of the esophagus, is equipped with an antireflux valve.
At the distal end, a delivery system of the HV STENT (fig. 2) is equipped with a soft tip, so-called olive, that is detachable such that once the sheath of the delivery system is being pulled back to allow the stent to expand, the olive is released first and simultaneously splits in halves (see still the fig. 2). Upon deployment of the HV STENT, the delivery system is removed whereas the halves of the olive pass out of the body naturally.
Stents of this kind of a construction such as HV STENT get shorten during expanding from the delivery system thus this feature shall be considered during deployment.

 

Fig. 1 - SX-ELLA Stent Esophageal HV (HV Stent)

hv

 Fig. 2 - Delivery system with an olive release system

 

hv




Miscellaneous important facts

  • A physician to implant the HV STENT stent shall be skilled appropriately.
  • Stent shall be introduced by using the ultra stiff guide wire only.
  • Stent implantation should be performed under fluoroscopic control.
  • Proximal end of the stent shall be placed out of the tumorous stricture, i.e. in a healthy tissue.
  • Instructions describing correction of stent misplacement/partial migration or its removal from the stomach after full migration shall be strictly followed. Changing the stent position after the period longer than 5 days from the date of implantation shall be well-considered because a part of the stent may be incorporated into the esophageal mucosal tissue at that time.
  • The patient shall eat semi-solid food and drink plenty of liquids.
  • Once even a small portion of the stent is released from the delivery system, it is strictly prohibited to push the delivery system forward to prevent an intussusception or a damage of the stent covering caused by a sheath edge.

Indications

  • Palliation of malignant or possibly benign esophageal strictures if a standard operation is contraindicated
  • Treatment of esophagorespiratory fistulas

Contraindications

  • Malignant or benign strictures in the upper part of the esophagus are too close to the cricopharyngeal muscle
  • Impossibility to dilate the esophageal stricture to the minimum diameter of 12 mm
  • Use of the valved stent shall be carefully considered in patients after partial gastrectomy - a distal end of the possibly migrated stent might impact on the gastric wall and consequently close the valve

Possible Complications

  • Stent migration
  • Improper positioning of stent
  • Obstruction of the stent by food
  • Decubital esophagorespiratory fistula caused by the flared end of the stent
  • Insufficient length of the stent
  • Tumor ingrowth/overgrowth
  • Fissuration of the esophageal wall
  • Allergic reaction
  • Local pain during 2 to 3 days after implantation

hv

hv hv
 
  כירורגיה
פלסטית
  אורטופדיה
   אנדוסקופיה
 
   ארתרוסקופיה
 
רדיולוגיה 
פולשנית
  אורולוגיה ואורוגניקולוגיה 
  גסטרואנטרולוגיה
  הרדמה וטיפול 
נמרץ
  כירורגיה




























































































































כל הזכויות שמורות - א.מ.י טכנולוגיות רפואיות בע"מ
המידע באתר זה הינו כללי ואינפורמטיבי בלבד. לייעוץ רפואי יש לפנות לרופא מומחה.

אודותינו  |  חטיבותמוצרים  | נציגויות  |  אסתטיקה רפואיתיצירת קשר  |  English
msite logo